ScoreWhy is Gufic BioSciences Ltd ?
1
The company has declared Negative results for the last 4 consecutive quarters
- INTEREST(Latest six months) At Rs 18.81 cr has Grown at 41.32%
- PAT(Latest six months) At Rs 29.89 cr has Grown at -29.89%
- ROCE(HY) Lowest at 10.87%
2
With ROCE of 11.3, it has a Very Expensive valuation with a 4.2 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -20.26%, its profits have fallen by -36.1%
3
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 2.12% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -20.26% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Gufic BioScience for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Gufic BioScience
-20.39%
-0.58
35.41%
Sensex
4.83%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
19.72%
EBIT Growth (5y)
21.52%
EBIT to Interest (avg)
5.46
Debt to EBITDA (avg)
2.11
Net Debt to Equity (avg)
0.45
Sales to Capital Employed (avg)
1.42
Tax Ratio
25.77%
Dividend Payout Ratio
1.16%
Pledged Shares
0
Institutional Holding
3.99%
ROCE (avg)
21.42%
ROE (avg)
11.91%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
63
Industry P/E
34
Price to Book Value
5.66
EV to EBIT
37.21
EV to EBITDA
29.30
EV to Capital Employed
4.22
EV to Sales
4.41
PEG Ratio
NA
Dividend Yield
0.03%
ROCE (Latest)
11.34%
ROE (Latest)
9.02%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
NET SALES(Q)
Highest at Rs 237.05 cr
-13What is not working for the Company
INTEREST(Latest six months)
At Rs 18.81 cr has Grown at 41.32%
PAT(Latest six months)
At Rs 29.89 cr has Grown at -29.89%
ROCE(HY)
Lowest at 10.87%
Loading Valuation Snapshot...
Here's what is working for Gufic BioScience
Net Sales - Quarterly
Highest at Rs 237.05 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Gufic BioScience
Interest - Latest six months
At Rs 18.81 cr has Grown at 41.32%
over previous Half yearly periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Profit After Tax (PAT) - Latest six months
At Rs 29.89 cr has Grown at -29.89%
Year on Year (YoY)MOJO Watch
Near term PAT trend is negative
PAT (Rs Cr)
Non Operating Income - Quarterly
Highest at Rs 2.12 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
